Health-insurance giant Humana is dropping a staggering 550,000 of its less profitable Medicare Advantage customers, or about ...
Humana stock has experienced significant fluctuations in recent years, but has historically been able to bounce back after market downturns. However, in 2024, Humana has faced challenges due to rising ...
Humana raised its 2025 guidance alongside the release of second quarter results that beat analyst expectations on Wednesday. It’s a bright spot for investors in the health insurance sector following ...
Zacks Investment Research on MSN
Why Humana deserves patience now: Too early to buy, too risky to sell
Humana Inc. HUM has tested investor conviction over the past year as rising medical costs, reimbursement uncertainty, and ...
Humana (HUM): Revisiting Valuation After Volatile Returns and Ongoing Medicare Advantage Uncertainty
Humana (HUM) has been on a choppy path lately, with the stock slipping over the past 3 months even as profits grow. That gap between earnings momentum and price is what matters now. See our latest ...
Wondering if Humana is quietly turning into a value opportunity after a rough stretch, or if the stock is cheap for a reason? Let us break down what the current share price is really telling us. After ...
Humana (HUM) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
The CEO of Humana (HUM), Bruce Broussard, began the earnings call with the following comment: …I'd like to start by stating the obvious. We are disappointed in the update provided today. As the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results